S303 Treated Red Blood Cells(Cerus)(S303 Treated Red Blood Cells(Cerus))

概要

基本信息

药物类型

细胞疗法

别名-

靶点-

作用方式-

作用机制

细胞替代物

治疗领域

遗传病与畸形血液及淋巴系统疾病其他疾病

在研适应症-

非在研适应症

贫血β地中海贫血

原研机构

Cerus Corp.

在研机构-

非在研机构

Cerus Corp.

权益机构-

最高研发阶段无进展临床3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 S303 Treated Red Blood Cells(Cerus) 相关的临床试验

NCT01716923

/ Completed临床3期

A Randomized Controlled Double-Blind Phase 3 Study to Assess Characteristics of S 303 Treated RBC Components and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia

The clinical study will assess the in-vitro characteristics of red blood cells (RBCs) per the European Union (EU) criteria for leukocyte depleted RBCs in additive solution and evaluate the safety and efficacy of S-303 treated RBCs in a patient population requiring RBC transfusion support for acute anemia.

开始日期2013-04-01

申办/合作机构

Cerus Corp.

NCT01740531

/ Completed临床3期

A Randomized Controlled Study to Evaluate Efficacy and Safety of S 303 Treated Red Blood Cells (RBC) in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion

To evaluate the efficacy and safety of S 303 treated red blood cells (RBCs) in subjects who require chronic transfusion support due to thalassemia major.

开始日期2012-12-01

申办/合作机构

Cerus Corp.

NCT01711346

/ Completed临床2期

A Randomized, Controlled, Single-Blind, 2-Period Crossover Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells

The objective of this study is to assess the post-infusion viability of S-303 Red Blood Cells (RBC) by measuring the 24 hour post-infusion recovery and lifespan of autologous RBCs prepared with the S-303 Treatment System for RBC after storage for 35 days in comparison to conventional untreated RBCs stored for 35 days.

开始日期2012-10-01

申办/合作机构

Cerus Corp.

100 项与 S303 Treated Red Blood Cells(Cerus) 相关的临床结果

登录后查看更多信息

100 项与 S303 Treated Red Blood Cells(Cerus) 相关的转化医学

登录后查看更多信息

100 项与 S303 Treated Red Blood Cells(Cerus) 相关的专利（医药）

登录后查看更多信息

100 项与 S303 Treated Red Blood Cells(Cerus) 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
贫血	临床3期	德国	Cerus Corp.	2013-04-01
β地中海贫血	临床3期	意大利	Cerus Corp.	2012-12-01
β地中海贫血	临床3期	土耳其	Cerus Corp.	2012-12-01